慢性阻塞性肺病
肺病
发病机制
受体
医学
肾上腺素能受体
疾病
肾上腺素能的
β2肾上腺素能受体
B2受体
自身抗体
内科学
生物信息学
免疫学
重症监护医学
生物
兴奋剂
抗体
缓激肽
作者
An‐Gang Yang,Ganggang Yu,Yanjun Wu,Haoyan Wang
出处
期刊:Life Sciences
[Elsevier]
日期:2021-01-01
卷期号:265: 118864-118864
被引量:13
标识
DOI:10.1016/j.lfs.2020.118864
摘要
Beta-2 adrenergic receptors (β2-ARs) have important roles in the pathogenesis and treatment of chronic obstructive pulmonary disease (COPD). In recent years, progress has been made in the study of β2-ARs. Here, we introduce the basic concepts of β2-ARs, related pathways, as well as application of blockers/agonists of β2-ARs, and β2-AR autoantibodies in COPD. Drugs targeting the β2-AR are being developed rapidly, and we expect them to improve the symptoms and prognosis of COPD patients in the future.
科研通智能强力驱动
Strongly Powered by AbleSci AI